| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ALL.12680 |
| P8608 | Fatcat ID | release_5dbuidkkmrehzn4mlaph2mfmhu |
| P698 | PubMed publication ID | 26119220 |
| P2093 | author name string | T K Hoffmann | |
| J Greve | |||
| M Bas | |||
| G Kojda | |||
| U Strassen | |||
| F Khosravani | |||
| P2860 | cites work | A randomized trial of icatibant in ACE-inhibitor-induced angioedema | Q39195095 |
| Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both | Q39669015 | ||
| Effect of C1-Esterase-inhibitor in angiotensin-converting enzyme inhibitor-induced angioedema | Q41590447 | ||
| Stability of murine bradykinin type 2 receptor despite treatment with NO, bradykinin, icatibant, or C1-INH. | Q41725429 | ||
| Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutations | Q41755059 | ||
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial | Q42542786 | ||
| AT1-receptor antagonism improves endothelial function in coronary artery disease by a bradykinin/B2-receptor-dependent mechanism | Q44374330 | ||
| Losartan increases bradykinin levels in hypertensive humans | Q45227736 | ||
| Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1. | Q46140760 | ||
| Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs | Q47276862 | ||
| Treatment of angiotensin receptor blocker-induced angioedema: A case series. | Q53621000 | ||
| Bradykinin–evoked sensitization of airway sensory nerves: A mechanism for ACE–inhibitor cough | Q56566517 | ||
| Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III | Q24671677 | ||
| Angiotensin-neprilysin inhibition versus enalapril in heart failure | Q28247091 | ||
| Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus | Q28297680 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Telmisartan, ramipril, or both in patients at high risk for vascular events | Q33156143 | ||
| Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function | Q33623829 | ||
| Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo | Q33829366 | ||
| Hereditary angioedema with normal C1-inhibitor activity in women | Q33915553 | ||
| Nonallergic angioedema: role of bradykinin | Q34647610 | ||
| Clinical management of hereditary angio-oedema in children. | Q34764718 | ||
| Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor | Q34790892 | ||
| Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema | Q36326043 | ||
| Renin-angiotensin system and cardiovascular risk | Q36784673 | ||
| Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department | Q37152144 | ||
| Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis | Q37340888 | ||
| Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema | Q37378498 | ||
| Current role of neprilysin inhibitors in hypertension and heart failure | Q38212419 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 1196-1200 | |
| P577 | publication date | 2015-06-26 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Angioedema induced by cardiovascular drugs: new players join old friends | |
| P478 | volume | 70 |
| Q88551011 | A score for the differential diagnosis of bradykinin- and histamine-induced head and neck swellings |
| Q88799272 | Angioedema |
| Q33559121 | Angioedema in the emergency department: a practical guide to differential diagnosis and management |
| Q90666310 | Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports |
| Q89456853 | Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients |
| Q33751504 | Drug-Induced Inhibition of Angiotensin Converting Enzyme and Dipeptidyl Peptidase 4 Results in Nearly Therapy Resistant Bradykinin Induced Angioedema: A Case Report |
| Q50215247 | Drug-induced angioedema : Focus on bradykinin |
| Q91973239 | Evaluation and Management of Angioedema in the Emergency Department |
| Q89811293 | Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment |
| Q28073074 | Personalized Medicine in Allergy |
| Q49710704 | The role of bradykinin receptor type 2 for spontaneous extravasation in mice skin: Implications for non-allergic angio-oedema. |
| Q90100443 | [Classification and pathophysiology of angioedema] |
Search more.